Molecular diagnosis of minimal residual disease in head and neck cancer patients.
Graveland AP, Braakhuis BJ, Eerenstein SE, de Bree R, Bloemena E, de Maaker M, van den Brekel MW, Dijk F, Mesker WE, Tanke HJ, Leemans CR, Brakenhoff RH.
Graveland AP, et al. Among authors: eerenstein se.
Cell Oncol (Dordr). 2012 Oct;35(5):367-75. doi: 10.1007/s13402-012-0097-1. Epub 2012 Sep 4.
Cell Oncol (Dordr). 2012.
PMID: 22945509